Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • NIH, Inova Launch 10K-Person Database For Re-Contact

    Mar 1, 2018, 11:45 AM by Michael Croft
    Bio-IT World News Brief | The National Institutes of Health and Inova Health System today announced The Genomic Ascertainment Cohort (TGAC), a two-year pilot project that will allow researchers to re-contact genotyped people and examine the genes and gene variants' influence on their phenotypes, an individual's observable traits, such as height, eye color or blood type.
    Full story
  • Saneca Pharma renews Pharmascience agreement following successful quality audit

    Mar 1, 2018, 10:51 AM by Michael Croft
    HLOHOVEC, SLOVAKIA - Mar 1, 2018 - Contract development and manufacturing organisation (CDMO) Saneca Pharma has renewed an agreement with Pharmascience Inc, one of Canada’s largest pharmaceutical companies, for the manufacture and supply of prescription medicines in tablet form
    Full story
  • 23andMe Adds 120 New Regions To Its Ancestry Test

    Feb 28, 2018, 14:49 PM by Michael Croft
    CNBC | At-home DNA testing company 23andMe is including 120 new regions in its ancestry report, making the test far more specific in its results.
    Full story
  • Riffyn Awarded Its First US Patent for Experiment Design and Data Analytics

    Feb 28, 2018, 09:58 AM by Michael Croft
    OAKLAND, CA, US - Feb 27, 2018 - Riffyn, a provider of cloud-based R&D software, announced that the United States Patent Office has granted its patent on a hypergraph data model for experiment design and data analysis (U
    Full story
  • Dovetail Genomics, Illumina, The Broad Institute, And More: News From February 2018

    Feb 28, 2018, 09:25 AM by Michael Croft

    Bio-IT World | February featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Dovetail Genomics, Illumina, The Broad Institute, and more.

    Full story
  • Equus Compute Solutions Launches Servers with New Intel® Xeon® Scalable CPUs

    Feb 27, 2018, 11:41 AM by Michael Croft
    EDINA, MN, UNITED STATES - Feb 27, 2018 - Equus Compute Solutions announced today the availability of servers that use the new Intel® Xeon® Processor Scalable Family (aka “Purley”)
    Full story
  • Certara Demonstrates Proof of Concept for its Virtual Twin™ Technology

    Feb 27, 2018, 08:54 AM by Michael Croft
    PRINCETON, NJ - Feb 27, 2018 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has published two papers demonstrating proof of concept for its Virtual Twin™ technology
    Full story
  • Leroy Hood On How Systems-Driven 21st Century Medicine Could Transform Healthcare

    Feb 27, 2018, 08:52 AM by Michael Croft
    Diagnostics World | During the 25th annual Molecular Medicine Tri-Conference in San Francisco, Leroy Hood of the Institute for Systems Biology and Providence St. Joseph Health discussed his latest efforts to transform medicine through pioneering a systems-driven approach.
    Full story
  • GA4GH Releases 2018 Strategic Roadmap

    Feb 26, 2018, 10:30 AM by Michael Croft

    Bio-IT World | The Global Alliance for Genomics and Health has announced their Strategic Roadmap, which the organization hopes will aid in the major shift toward genomics becoming useful in healthcare.

    Full story
  • Elsevier collaborates with Beijing University of Chinese Medicine to enable deeper research into traditional Chinese medicine

    Feb 26, 2018, 10:15 AM by Michael Croft
    , NY - Feb 26, 2018 - As global interest in traditional and alternative medicine grows, Elsevier, the global information analytics business specializing in science and health, today announced that it is working with Beijing University of Chinese Medicine (BUCM) to create a new taxonomy for traditional Chinese medicine (TCM) in Embase, the world’s most comprehensive biomedical literature database
    Full story
  • CRF Health Scoops 2018 TrialConsent® Hat Trick as CARE Award Finalist

    Feb 26, 2018, 09:02 AM by Michael Croft
    PLYMOUTH MEETING, PA - Feb 26, 2018 - CRF Health, the leading provider of patient-centered eSource for the life sciences industry, today announced that its TrialConsent® electronic informed consent solution has been shortlisted for the ‘Best Patient-Focused Technological Development’ category in the 2018 Clinical & Research Excellence (CARE) Awards
    Full story
  • Prokarium secures $10 million investment from Saudi, Swedish and Korean investors for clinical development of revolutionary thermostable vaccines

    Feb 26, 2018, 05:43 AM by Michael Croft
    KEELE, UK - Feb 26, 2018 - Prokarium, the UK-based synthetic biology company that has developed Vaxonella, an oral, thermostable vaccine delivery platform, today announced the completion of a $10 million investment round
    Full story
  • Changing Cancer Research: Biden Cancer Initiative On What’s Next

    Feb 23, 2018, 14:10 PM by Michael Croft

    Bio-IT World | Gregory Simon, President of the Biden Cancer Initiative, discussed the current state of cancer treatment during his keynote address at the 25th annual Molecular Medicine Tri-Conference last week. “What I’m going to talk to you about today,” Simon said, “is changing the way we think about what we’re doing in [cancer] research.”

    Full story
  • MasterControl Introduces Groundbreaking Software Validation Tool

    Feb 23, 2018, 11:23 AM by Michael Croft
    SALT LAKE CITY, UT, UNITED STATES - Feb 23, 2018 - MasterControl Inc., a leading global provider of software solutions that enable life science and other regulated companies to deliver life-improving products to more people sooner, today announced MasterControl Validation Excellence Tool (VxT) a new, industry-first solution to enable companies required to conduct risk-based software validation to reduce the time from months down to days or hours
    Full story
  • OCF Petascale Supercomputer at University of Southampton enters TOP500

    Feb 22, 2018, 10:39 AM by Michael Croft
    SOUTHAMPTON, UNITED KINGDOM - Feb 22, 2018 - Researchers from across the University of Southampton are benefitting from a new High Performance Computing (HPC) machine named Iridis, which has entered the TOP500, debuting at 251 on the list
    Full story
  • Share The Data: David Haussler Envisions A New Future For Pediatric Cancer

    Feb 22, 2018, 09:15 AM by Michael Croft

    Bio-IT World | David Haussler, Professor and Scientific Director of the UC Santa Cruz Genomics Institute, came to the 25th annual Molecular Medicine Tri-Conference to discuss using the power of big data to help pediatric cancer patients.

    Full story
  • CRISPR In China: Cancer Treatment With Gene Editing Underway

    Feb 21, 2018, 10:52 AM by Michael Croft
    NPR | More than a third of patients with cancer of the esophagus responded to experimental treatment in China with the gene-editing technique CRISPR. Several CRISPR studies are underway there.
    Full story
  • 100,000 Genomes Project Reaches Halfway Milestone

    Feb 20, 2018, 16:15 PM by Michael Croft

    Bio-IT World Brief | The United Kingdom’s pioneering 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes.

    Full story
  • Doctors Said Immunotherapy Would Not Cure Her Cancer. They Were Wrong.

    Feb 19, 2018, 12:48 PM by Michael Croft
    The New York Times | Scientists are racing to understand why immunotherapy drugs have worked for a few cancer patients when the medicines should have had no effect.
    Full story
  • Ambry Genetics and Invicro Announce Partnership to Provide Enhanced Capabilities with Advanced Genomics Services to Enable Precision Medicine

    Feb 16, 2018, 19:52 PM by Michael Croft
    ALISO VIEJO, CA - Feb 1, 2018 - Ambry Genetics Corporation (Ambry), leaders in genetic testing, announced today they will partner with Invicro, a leading provider of imaging services and software for research and drug development, to provide customized genomics and imaging services for the pharmaceutical and biotechnology industry, with a specialized focus on oncology and neurodegenerative diseases
    Full story
  • «
  • 271
  • 272
  • 273
  • 274
  • 275
  • 276
  • 277
  • 278
  • 279 (current)
  • 280
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy